These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33732305)

  • 1. Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy.
    Zhang Y; Gao Z; Zhang X; Yuan Z; Ma T; Li G; Gao X
    Exp Ther Med; 2021 Apr; 21(4):332. PubMed ID: 33732305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.
    Zhang X; Wu J; Wu C; Bian AL; Geng S; Dai RP
    Diabetes Res Clin Pract; 2020 Apr; 162():108083. PubMed ID: 32057965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection.
    Zhou J; Liu Z; Chen M; Luo ZH; Li YQ; Qi GY; Liu T
    Diabetes Ther; 2018 Dec; 9(6):2393-2398. PubMed ID: 30377995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
    Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
    BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.
    Ding Y; Su N; Luan J; Ni Y; Sun Z
    J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study on the Drug Concentration in Fellow Eyes After Unilateral Intravitreal Injection of Conbercept Into New Zealand Rabbit Eyes.
    Di Y; Xu H; Ye J; Guo Z
    Front Pharmacol; 2021; 12():783057. PubMed ID: 34925038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy.
    Huang Z; Chen LJ; Huang D; Yi J; Chen Z; Lin P; Wang Y; Zheng J; Chen W
    J Diabetes Res; 2024; 2024():2550367. PubMed ID: 39308630
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular endothelial growth factor/connective tissue growth factor and proteomic analysis of aqueous humor after intravitreal conbercept for proliferative diabetes retinopathy.
    Li HS; Lyu X; Rong A; Bi YL; Xu W; Cui HP
    Int J Ophthalmol; 2024; 17(10):1816-1827. PubMed ID: 39430009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy.
    Yang Z; Di Y; Ye J; Yu W; Guo Z
    Front Endocrinol (Lausanne); 2023; 14():1171628. PubMed ID: 37305048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pars plana vitrectomy assisted by intravitreal injection of conbercept enhances the therapeutic effect and quality of life in patients with severe proliferative diabetic retinopathy.
    Wang Q; Cai H; Xu D; Cui L; Zhang Y; Chen M
    Am J Transl Res; 2022; 14(2):1324-1331. PubMed ID: 35273734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of RBP4 in the vitreous humour of patients with proliferative diabetic retinopathy who underwent Conbercept intravitreal injection.
    Wen D; Ren X; Li H; He Y; Hong Y; Cao J; Zheng C; Dong L; Li X
    Exp Eye Res; 2022 Dec; 225():109197. PubMed ID: 35932904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept.
    Du L; Peng H; Wu Q; Zhu M; Luo D; Ke X; Yang P; Lei B
    Mol Vis; 2015; 21():185-93. PubMed ID: 25737631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy.
    Mao JB; Wu HF; Chen YQ; Zhao SX; Tao JW; Zhang Y; Zheng B; Wang L; Shen LJ
    Int J Ophthalmol; 2018; 11(7):1217-1221. PubMed ID: 30046542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.
    Sun C; Zhang H; Jiang J; Li Y; Nie C; Gu J; Luo L; Wang Z
    Int Ophthalmol; 2020 Feb; 40(2):467-475. PubMed ID: 31802372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.
    Yang X; Xu J; Wang R; Mei Y; Lei H; Liu J; Zhang T; Zhao H
    J Ophthalmol; 2016; 2016():2473234. PubMed ID: 27034822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
    Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
    Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy.
    Tsubota K; Usui Y; Wakabayashi Y; Suzuki J; Ueda S; Goto H
    Clin Ophthalmol; 2019; 13():1063-1070. PubMed ID: 31303746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
    Wu S; He X
    Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.